Glycogen storage disease type IX: Long-term follow-up of 52 patients from three European countries. [PDF]
Magner M +17 more
europepmc +1 more source
Improvement of Symptoms in a Patient With Glycogen Storage Disease Through Nutritional Guidance and Exercise Therapy. [PDF]
Morita T +5 more
europepmc +1 more source
Noninfectious endocarditis as a novel cardiac manifestation of glycogen storage disease type IV: a case report. [PDF]
Kingdon T +5 more
europepmc +1 more source
Clinical and molecular characterization of hepatic glycogen storage disease in Saudi Arabia. [PDF]
Al-Hussaini A +14 more
europepmc +1 more source
Liver-directed AAV gene therapy in mice corrects glycogen storage disease type IX γ2. [PDF]
Gibson RA +9 more
europepmc +1 more source
Glycogen storage disease type Ia complicated by gestational hypertriglyceridemic pancreatitis: A rare case report. [PDF]
Zhang Y +5 more
europepmc +1 more source
Hepatocyte-specific Cas9-mediated editing of G6pc and Slc37a4 elicits comparable biochemical and regulatory responses between glycogen storage disease (GSD) type Ia and Ib mice. [PDF]
Krishnamurthy KA +17 more
europepmc +1 more source
Efficacious genome editing in infant mice with glycogen storage disease type Ia. [PDF]
Arnson B +13 more
europepmc +1 more source
Unifying the Communities of Early-Onset Glycogen Storage Disease Type IV and Adult Polyglucosan Body Disease Through a Genetic Prevalence Study of <i>GBE1</i>-Related Disease. [PDF]
Koch RL +13 more
europepmc +1 more source
Empagliflozin as treatment in glycogen storage disease type IB patients. [PDF]
Arbelo Rodríguez M +6 more
europepmc +1 more source

